<?xml version="1.0" encoding="UTF-8"?>
<p id="p0245">The use of digital tools during the pandemic has also been remarkable and has facilitated the continuity of business operations. It has provided the opportunity for the pharmaceutical sector to reevaluate the use of tools to ensure that they are able to facilitate the efficient functioning of regulatory processes and operations that ensure that medicines are developed and made available to patients. More importantly, this pandemic has underscored the importance and the benefit of working across all stakeholders, which can be continuously leveraged even postpandemic. A robust, coordinated approach will be beneficial, given the shared aims of ending the pandemic, ensuring a healthy population, and better managing emergency situations in the future.</p>
